Cargando…

Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

Introduction: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i), gliflozins, play an emerging role for the treatment of heart failure with reduced left ventricular ejection fraction (HFrEF). Nevertheless, the effects of SGLT2i on ventricular remodeling and function have not been completely und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mele, Marco, Imbrici, Paola, Mele, Antonietta, Togo, Maria Vittoria, Dinoi, Giorgia, Correale, Michele, Brunetti, Natale Daniele, Nicolotti, Orazio, De Luca, Annamaria, Altomare, Cosimo Damiano, Liantonio, Antonella, Amoroso, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289166/ https://www.ncbi.nlm.nih.gov/pubmed/37361206 http://dx.doi.org/10.3389/fphar.2023.1175606

Ejemplares similares

Brugada Syndrome: More than a Monogenic Channelopathy
por: Liantonio, Antonella, et al.
Publicado: (2023)

Sarcoplasmic Reticulum Ca(2+) Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease
por: Conte, Elena, et al.
Publicado: (2023)

Making sense of chemical space network shows signs of criticality
por: Amoroso, Nicola, et al.
Publicado: (2023)

Gliflozine – in Zukunft Kardioprotektiva?
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2021)

Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
por: Correale, Michele, et al.
Publicado: (2023)

Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications
por: Mele, Antonietta, et al.
Publicado: (2023)

Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia
por: Dinoi, Giorgia, et al.
Publicado: (2022)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases
por: Coppola, Maria Antonietta, et al.
Publicado: (2023)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
por: Heyman, Samuel N., et al.
Publicado: (2023)

Alteration of STIM1/Orai1-Mediated SOCE in Skeletal Muscle: Impact in Genetic Muscle Diseases and Beyond
por: Conte, Elena, et al.
Publicado: (2021)

Therapy of Type 2 diabetes: more gliflozines and less metformin?
por: Verdecchia, Paolo, et al.
Publicado: (2023)

Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes
por: Bragagni, Alessio, et al.
Publicado: (2021)

Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy—A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure
por: Pistelli, Lorenzo, et al.
Publicado: (2023)

ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force
por: Tricarico, Domenico, et al.
Publicado: (2016)

Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl(−)/H(+) Antiporters
por: Coppola, Maria Antonietta, et al.
Publicado: (2023)

Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif
por: Pisani, Leonardo, et al.
Publicado: (2016)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
por: de Pouvourville, Gérard, et al.
Publicado: (2023)

First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
por: Purgatorio, Rosa, et al.
Publicado: (2021)

Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases
por: Purgatorio, Rosa, et al.
Publicado: (2022)

A twenty-year journey exploring coumarin-based derivatives as bioactive molecules
por: Pisani, Leonardo, et al.
Publicado: (2022)

SAVOR-TIMI to DECLARE-TIMI: A Review on Cardiovascular Outcome Trials of Incretin-modulators and Gliflozins
por: Singh, Awadhesh K., et al.
Publicado: (2019)

Gliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials
por: Zhao, Li-Min, et al.
Publicado: (2021)

Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials
por: Yin, Daogen, et al.
Publicado: (2021)

Metabolism and Chemical Degradation of New Antidiabetic Drugs: A Review of Analytical Approaches for Analysis of Glutides and Gliflozins
por: Gumieniczek, Anna, et al.
Publicado: (2023)

Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease †
por: Purgatorio, Rosa, et al.
Publicado: (2020)

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
por: Patorno, Elisabetta, et al.
Publicado: (2018)

Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
por: Monda, Vincenzo Maria, et al.
Publicado: (2021)

Coronary thrombosis due to heparin‐induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent
por: Mele, Marco, et al.
Publicado: (2020)

Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction
por: Alcidi, Gianmarco, et al.
Publicado: (2023)

Sensory-Motor Modulations of EEG Event-Related Potentials Reflect Walking-Related Macro-Affordances
por: Tosoni, Annalisa, et al.
Publicado: (2021)

I–J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes
por: Gradogna, Antonella, et al.
Publicado: (2014)

Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches
por: D’Adamo, Maria Cristina, et al.
Publicado: (2020)

Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options
por: Camerino, Giulia Maria, et al.
Publicado: (2019)

Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia
por: Mantuano, Paola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lcev8m5pk70557et6dubqctpod